Dumont & Blake Investment Advisors’s ResMed RMD Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-10,395	Closed	-$746K	–	172
2015 Q1	$746K	Buy	10,395 +65	+0.6%	+$4.22K	0.36%	102
2014 Q4	$579K	Hold	10,330	–	–	0.29%	111
2014 Q3	$509K	Hold	10,330	–	–	0.26%	118
2014 Q2	$523K	Sell	10,330 -50	-0.5%	-$2.48K	0.26%	119
2014 Q1	$464K	Buy	+10,380	New	+$466K	0.24%	118

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dumont & Blake Investment Advisors's RMD Position: Q2 2015 in Review

Dumont & Blake Investment Advisors sold out of ResMed (RMD) in Q2 2015, closing a stake of 10,395 shares — an estimated $746K sold.

Dumont & Blake Investment Advisors first reported a position in RMD in Q1 2014 and held it in 5 quarters. The position peaked at $746K in Q1 2015. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2015.

Dumont & Blake Investment Advisors reported no remaining ResMed position as of Q2 2015 after selling out during the quarter.
Dumont & Blake Investment Advisors sold 10,395 ResMed shares in Q2 2015, an estimated $746K.
Dumont & Blake Investment Advisors first reported a position in ResMed in Q1 2014 and held it in 5 quarters.
Dumont & Blake Investment Advisors's ResMed position peaked at $746K in Q1 2015.
312 funds tracked by Wall St. Rank held ResMed as of Q2 2015.

Based on Dumont & Blake Investment Advisors's 13F filing for Q2 2015, filed 20 Jul 2015.